CSIMarket Company Name, Ticker, Suppliers, else..
 
Brainsway Ltd   (NASDAQ: BWAY)
Other Ticker:  
 
 
Price: $10.6900 $-0.24 -2.196%
Day's High: $11.19 Week Perf: 4.5 %
Day's Low: $ 10.65 30 Day Perf: 15.69 %
Volume (M): 30 52 Wk High: $ 11.25
Volume (M$): $ 321 52 Wk Avg: $7.45
Open: $10.93 52 Wk Low: $4.61



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 145
 Revenues (TTM) (Millions $) 32
 Net Income (TTM) (Millions $) 4
 Cash Flow (TTM) (Millions $) 48
 Capital Exp. (TTM) (Millions $) 0

Brainsway Ltd
Brainsway Ltd is a medical technology company that specializes in developing and marketing non-invasive brain stimulation systems for the treatment of various neurological and psychiatric disorders. The company is known for its deep transcranial magnetic stimulation (dTMS) technology, which delivers magnetic fields to specific areas of the brain. Brainsway's products are used by healthcare professionals worldwide for conditions such as major depressive disorder, obsessive-compulsive disorder, and smoking addiction. The company aims to provide innovative and effective solutions to improve the quality of life for individuals suffering from these disorders.


   Company Address: 19 Hartum Street Jerusalem 9777518
   Company Phone Number: 2-582-4030   Stock Exchange / Ticker: NASDAQ BWAY


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ECOR      % 
MDT      % 
NVRO      % 
SRTS      % 
STIM      % 
TIVC      % 
• View Complete Report
   



Product Service News

BrainsWay Pioneers New Frontiers in Mental Health Promising TMS Data for Alcohol Use Disorder and Significant E...

Published Thu, Dec 12 2024 1:00 PM UTC

In a noteworthy advancement for the field of mental health treatment, BrainsWay Ltd. (NASDAQ & TASE: BWAY), a prominent player in non-invasive brain disorder therapies, unveiled positive independent pilot data from a study conducted at Stanford University. This research evaluates an accelerated protocol using the company?s sophisticated Deep Transcranial Magnetic Stimulation...
Clinical Study

Efficacy of Deep Transcranial Magnetic Stimulation in Pain Management Feasibility Study Findings from BrainsWay Ltd

Published Wed, Nov 20 2024 1:00 PM UTC

Abstract: Emerging evidence suggests that Deep Transcranial Magnetic Stimulation (Deep TMS) may offer a promising alternative for managing pain symptoms, particularly in patients with comorbid mental health disorders. Recent feasibility data released by BrainsWay Ltd (NASDAQ: BWAY) reveals significant reductions in pain, anxiety, and depression symptoms associated with the...
Product Service News

Global Reach and Innovative Horizons BrainsWay?s Strategic Expansion in Neurostimulation Technology

Published Wed, Oct 9 2024 11:30 AM UTC

BrainsWay Ltd. is charting an ambitious course as a leader in the realm of noninvasive neurostimulation treatments. With a strategic push to expand its presence in East Asia, complemented by a robust network growth in the Western United States, the company is not only broadening its geographical footprint but also reinforcing its significant contributions to mental health ...
Financing Agreement

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

Published Mon, Sep 30 2024 11:30 AM UTC

BrainsWayns Strategic Expansion and Financial Maneuvering: A New Chapter in Mental Health CareIn a rapidly changing landscape where mental health issues dominate societal concerns, BrainsWay Ltd. is poised to solidify its position as a leader in innovative treatments. The company, recognized for its cutting-edge transcranial magnetic stimulation (TMS) technologies, has rece...
Product Service News

BrainsWays Expansion Signals a New Era in Mental Health Treatment on the U.S. East Coast

Published Mon, Sep 16 2024 11:30 AM UTC

In a striking move indicative of the rapidly evolving landscape of mental health treatment, BrainsWay, a leader in innovative transcranial magnetic stimulation (TMS) technologies, has announced a significant expansion into the U.S. East Coast. The company recently secured an order for 14 of its advanced Deep TMS devices from a prominent mental health network, underscoring th...









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com